Life-Sciences-Europe.com
The European Life Sciences Web Portal

This is a free web portal for the life sciences in Europe and Israel... » read more

Atlas Antibodies AB Acquires Swiss-based Evitria SA (2021-07-28)
Atlas Antibodies has agreed to acquire evitria, a world leader in transient recombinant antibody expression in CHO cells. This transformative acquisition brings together a leading provider of highly validated research antibodies and a front-runner in the field of c...
Brain Biotech & Sartorius Partner for CRISPR Cas-nucleases (2021-07-28)
The life science group Sartorius and BRAIN Biotech AG are jointly researching and adapting novel CRISPR-Cas genome editing nucleases for specific applications in the field of life sciences. Genome editing enables the targeted and precise insertion, deletion, or mod...
Atai Life Sciences & Univ of Queensland Launch InnarisBio (2021-07-28)
atai Life Sciences launches InnarisBio, in partnership with the University of Queensland, with the aim to develop a more effective nose-to-brain delivery method for atai’s platform of mental health therapeutic programs atai Life Sciences (“atai” or the “Compan...
Artios Pharma Closes £110m Series C Led Round (2021-07-27)
> Funding propels Artios’ ability to progress beyond synthetic lethality and to continue the exploitation of the full spectrum of oncology vulnerabilities presented by the DNA Damage Response through deployment of Artios’ DDR-based platform and small molecule drug ...
SynOx Therapeutics Appoints New Chairman & New CEO (2021-07-27)
> Plans to initiate a pivotal trial for patients suffering from Tenosynovial Giant Cell Tumours (TGCT) > Follows €37 M Series A investment to progress emactuzumab, a potentially best-in-class CSF-1R antibody licensed on an exclusive, worldwide basis from Roche ...
Byondis and Glycotope Enter Platform Access Agreement (2021-07-27)
Byondis B.V., an independent, clinical stage biopharmaceutical company creating precision medicines, and Glycotope, a biotechnology company developing antibodies against proteins carrying tumor-specific carbohydrate structures, have entered into a platform access a...
AC Immune: Raises $25m, Acquires Affiris’ PD Assets (2021-07-27)
> All-stock transaction maintains AC Immune’s strong cash position > USD 25 million private placement led by premier investor Athos Service GmbH > Transactions expand and accelerate AC Immune’s therapeutic development in Parkinson’s disease > AC Immune to ...
Cevec Closes Growth Financing Round: NRW.Bank Participates (2021-07-27)
> With its highly scalable Adenovirus and AAV production technologies, CEVEC provides cutting-edge manufacturing solutions for two of the most widely used gene therapy vectors > Funding will expand cell line development capacities for ELEVECTA® stable AAVproduce...
Metrion Biosciences Appoints Nick Foster as CCO (2021-07-26)
Appointment supports international growth within ion channel contract research and drug discovery Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced the appointment of Nick Foste...
Relief Therapeutics Announces CHF15m Private Placement (2021-07-26)
Ad Hoc Announcement pursuant to Art. 53 LR RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief" or the "Company"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, today announc...

» Show all News!

Life-Sciences-Europe.com is your doorway to the European life sciences!

[LSE] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!

» Start here with the latest News!

Picture EBD Group Global Partnering Four Events One Price 650x80

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]